Literature DB >> 910639

The hepatic conversion of vitamin D in alcoholics with varying degrees of liver affection.

B Lund, O H Sorensen, M Hilden, B Lund.   

Abstract

The seasonal variations in circulating 25-hydroxycholecalciferol (25-HCC) were studied in 102 alcoholics with fatty liver disease without histologic signs of cirrhosis and in 35 patients with alcoholic cirrhosis. The mean levels were compared with those of normal persons. Alcoholics had generally lower 25-HCC values than the controls, particularly in the summer. This was primarily explained by insufficient diet and reduced exposure to sunshine. The ability of the liver to hydroxylate in the 25-position was studied in three groups of alcoholics with 1) fatty liver disease without cirrhosis, 2) compensated cirrhosis, 3) severely incompensated liver cirrhosis. All three groups exhibited a significant increase in serum 25-HCC following the peroral administration of cholecalciferol at a dose of 1 200 U daily for 7 days. Similar rises were seen 7 days after a single injection of 10 000 U cholecalciferol. This indicates a normal intestinal absorption of vitamin D, even in advanced alcoholic liver disease, and is inconsistent with a severely damaged 25-hydroxylation capacity in these patients. Osteomalacia due to impaired liver hydroxylation of vitamin D can hardly explain the increased fracture rate and the decreased bone mass, which have been described in alcoholics.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 910639     DOI: 10.1111/j.0954-6820.1977.tb16815.x

Source DB:  PubMed          Journal:  Acta Med Scand        ISSN: 0001-6101


  8 in total

1.  Alcoholism-associated spinal and femoral bone loss in abstinent male alcoholics, as measured by dual X-ray absorptiometry.

Authors:  K S Chon; D J Sartoris; S A Brown; P Clopton
Journal:  Skeletal Radiol       Date:  1992       Impact factor: 2.199

Review 2.  Bone changes in alcoholic liver cirrhosis. A histomorphometrical analysis of 52 cases.

Authors:  J A Jorge-Hernandez; C E Gonzalez-Reimers; A Torres-Ramirez; F Santolaria-Fernandez; C Gonzalez-Garcia; J N Batista-Lopez; M Pestana-Pestana; L Hernandez-Nieto
Journal:  Dig Dis Sci       Date:  1988-09       Impact factor: 3.199

3.  METABOLIC BONE DISEASE AND REVERSIBLE RENAL TUBULAR DYSFUNCTION IN A CHRONIC ALCOHOLIC.

Authors:  M K Garg; N Tandon
Journal:  Med J Armed Forces India       Date:  2017-06-08

4.  Free 25-hydroxyvitamin D levels are normal in subjects with liver disease and reduced total 25-hydroxyvitamin D levels.

Authors:  D D Bikle; B P Halloran; E Gee; E Ryzen; J G Haddad
Journal:  J Clin Invest       Date:  1986-09       Impact factor: 14.808

Review 5.  Hepatic osteodystrophy: vitamin D metabolism in patients with liver disease.

Authors:  J E Compston
Journal:  Gut       Date:  1986-09       Impact factor: 23.059

6.  Abnormal vitamin D3 metabolism in patients with primary Sjögren's syndrome.

Authors:  K Müller; P Oxholm; O H Sørensen; M Thymann; M Høier-Madsen; K Bendtzen
Journal:  Ann Rheum Dis       Date:  1990-09       Impact factor: 19.103

7.  Chronic ethanol consumption leads to disruption of vitamin D3 homeostasis associated with induction of renal 1,25 dihydroxyvitamin D3-24-hydroxylase (CYP24A1).

Authors:  Kartik Shankar; Xiaoli Liu; Rohit Singhal; Jin-Ran Chen; Shanmugam Nagarajan; Thomas M Badger; Martin J J Ronis
Journal:  Endocrinology       Date:  2007-12-27       Impact factor: 4.736

Review 8.  Micro-ribonucleic acids: potential noninvasive biomarkers for hepatocellular carcinoma.

Authors:  Limin Li; Wenli Diao; Ke Zen
Journal:  J Hepatocell Carcinoma       Date:  2014-05-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.